查看完整行情页>>

|

货币单位:美元(USD)

吉利德科学公司

Gilead Sciences, Inc. (gild)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Flavius Martin Currently, Flavius Martin holds the position of Executive Vice President-Research at Gilead Sciences, Inc. Dr. Martin previously held the position of Vice President-Research Biology at Amgen, Inc. He received a doctorate from Universitatea de Medicina si Farmacie Victor Babes.
Daniel P. O'Day Currently, Daniel P. O'Day is Chairman & Chief Executive Officer for Gilead Sciences, Inc. He is also on the board of Galapagos NV, Pharmaceutical Manufacturers Association of America and Shanghai Roche Pharmaceuticals Ltd. and Chairman of Pharmaceutical Research & Manufacturers of America. In the past Mr. O'Day was CEO-Roche Pharmaceuticals at Roche Holding AG Chief Executive Officer for Roche Pharmaceuticals, Inc. President & Chief Executive Officer for Roche Molecular Systems, Inc. Chief Operating Officer for Roche Diagnostics A, Head-Corporate Planning at Roche Diagnostics KK, Head-Business Unit, Arthritis & Respiratory at Roche Pharma (Schweiz) AG and General Manager at Roche A (which are all subsidiaries of Roche Holding AG). He received an undergraduate degree from Georgetown University and an MBA from The Trustees of Columbia University in The City of New York.
Merdad V. Parsey Merdad V. Parsey holds the position of Chief Medical Officer for Gilead Sciences, Inc. Dr. Parsey is also on the board of Sagimet Biosciences, Inc. (former President, Co-Chief Executive Officer & Director), Transcelerate Biopharma, Inc. and Arcus Biosciences, Inc. Dr. Parsey previously occupied the position of Senior Medical Director at Regeneron Pharmaceuticals, Inc., Associate Medical Director at Merck & Co., Inc., Senior Medical Director at Sumitomo Pharma America, Inc., Senior Director-Medical Group at Genentech, Inc., Member of Roche Group and Director-Critical Care Medicine at New York University School of Medicine. Merdad V. Parsey received a doctorate from the University of Maryland.
Christi L. Shaw Christi L. Shaw founded More Moments More Memories Foundation. Ms. Shaw is on the board of Biotechnology Innovation Organization, Avantor, Inc. and Beam Therapeutics, Inc. In her past career Ms. Shaw occupied the position of Principal at Johnson & Johnson Group Product Director at Janssen Pharmaceuticals, Inc. and VP-New Business Development & Strategic Analytics at Ethicon Corp. (both are subsidiaries of Johnson & Johnson), President-Bio Medicines & Senior Vice President at Eli Lilly & Co., Advisor at Concord Health Partners LLC, Chief Executive Officer at Kite Pharma, Inc., President & Country Head-US at Novartis Pharmaceuticals Corp. and Head-North American Region at Novartis Oncology, Inc. Ms. Shaw received an MBA from the University of Wisconsin and an undergraduate degree from Iowa State University.
Johanna Mercier Johanna Mercier is on the board of Neurocrine Biosciences, Inc., Robert Wood Johnson University Hospital, Inc., Arcus Biosciences, Inc. and Leonard D Schaeffer Center For Health Policy & Economics and Chief Commercial Officer of Gilead Sciences, Inc. and Member of World 50, Inc. Johanna Mercier previously occupied the position of President-US Commercial at Bristol Myers Squibb Co. She received an MBA from Concordia University and an undergraduate degree from the University of Montréal.
Andrew D. Dickinson Andrew D. Dickinson is on the board of Sutter Health, Fosun Kite Biotechnology Co., Ltd. and Gilead Sciences Ltd. and Chief Financial Officer for Gilead Sciences, Inc. In the past he occupied the position of Co-Head-Healthcare Investment Banking at Lazard, Inc., Founding Partner of Kendall Dickinson & Koenig LLC and Secretary, Vice President & General Counsel at Gilead Colorado, Inc. He received a graduate degree from Loyola University of Chicago and an undergraduate degree from The University of Colorado.
Anthony Welters Founder of CINQ Care, Inc., AmeriChoice Corp. and Somatus, Inc., Anthony Welters is an entrepreneur and businessperson who has been the head of 6 different companies and presently holds the position of Executive Chairman for BlackIvy Group LLC, Chairman of Somatus, Inc. and Chairman & Chief Executive Officer of CINQ Care, Inc. Mr. Welters is also Member of Smithsonian National Museum of American History, Member of American Academy of Arts & Sciences, Member of The District of Columbia Bar, Member of The New York Bar Foundation and Member of The National Museum of African American History & Culture and on the board of 17 other companies. Anthony Welters previously occupied the position of Executive Vice President at UnitedHealth Group, Inc. and President & Chief Executive Officer of AmeriChoice Corp. (a subsidiary of UnitedHealth Group, Inc.). He received an undergraduate degree from Manhattanville College and a graduate degree from New York University School of Law.
Jeffrey A. Bluestone Founder of Immune Tolerance Network, Sonoma Biotherapeutics, Inc., Xconomy, Inc. and Celsius Therapeutics, Inc., Jeffrey A. Bluestone holds the position of President, Chief Executive Officer & Director at Sonoma Biotherapeutics, Inc. and Chief Executive Officer for Xconomy, Inc. Dr. Bluestone is also on the board of Gilead Sciences, Inc. and The Parker Institute For Cancer Immunotherapy (former President & Chief Executive Officer) and Professor at The University of California, San Francisco, Member of American Academy of Arts & Sciences and Member of National Academy of Medicine (United States). In his past career Dr. Bluestone was Director at Immune Tolerance Network and Director & Professor at The Ben May Department For Cancer Research. Dr. Bluestone received a graduate degree from Rutgers State University of New Jersey and a doctorate from Weill Cornell Graduate School of Medical Sciences.
Kelly A. Kramer Currently, Kelly A. Kramer occupies the position of Senior Advisor at Consello Capital LLC. Ms. Kramer is also on the board of 5 other companies. In her past career she occupied the position of Chief Financial Officer & Executive Vice President at Cisco Systems, Inc., Chief Financial Officer of Global Life Sciences Solutions USA LLC and CFO-Healthcare Systems Business & Vice President at GE Healthcare, Inc. She received an undergraduate degree from Purdue University.
Jacqueline K. Barton Jacqueline K. Barton founded GeneOhm Sciences, Inc. Dr. Barton is on the board of Gilead Sciences, Inc. and Member of The Royal Society of Chemistry, Professor at California Institute of Technology, Member of National Academy of Sciences, Member of American Academy of Arts & Sciences, Member of National Academy of Medicine (United States) and Vice President & Member at American Philosophical Society. In the past Jacqueline K. Barton occupied the position of Professor at The Trustees of Columbia University in The City of New York, Assistant Professor at Hunter College and Director at GeneOhm Sciences, Inc. Dr. Barton received a doctorate from The Trustees of Columbia University in The City of New York and an undergraduate degree from Barnard College.
Sandra J. Horning Sandra J. Horning founded EQRx, Inc. and EQRx International, Inc. She is Professor-Emeritus at Stanford University School of Medicine and on the board of 5 other companies. In the past she occupied the position of Chief Medical Officer & Head-Product Development at Roche, Inc., EVP-Global Development at Genentech, Inc., Chief Medical Officer of Roche Holdings, Inc., President of American Society of Clinical Oncology, Inc. and Independent Director at EQRx, Inc. Sandra J. Horning received a doctorate and an undergraduate degree from the University of Iowa.
Kevin E. Lofton Kevin E. Lofton is a businessperson who has been at the helm of 8 different companies is on the board of Gilead Sciences, Inc. and 4 other companies. Mr. Lofton previously was Chief Executive Officer for UAB Health Systems, Chief Executive Officer & Executive Director at UAB Hospital, Chief Executive Officer of Catholic Health Initiatives, Chief Operating Officer & Executive Vice President at Shands Jacksonville Medical Center, Inc., Chairman-Trustees Board at American Hospital Association, Inc., Co-Chief Executive Officer & Trustee at Dignity Health, Chief Executive Officer & Trustee at CommonSpirit Health (Illinois), Chief Executive Officer & Executive Director at Howard University Hospital, Chief Executive Officer of The University of Alabama at Birmingham and Chief Operating Officer & Executive Vice President of University Medical Center. Mr. Lofton received a graduate degree from Georgia State University and an undergraduate degree from Boston University.
Javier J. Rodriguez Founder of DomoBlue SL, Javier J. Rodriguez presently is Chief Executive Officer of CEO Action For Diversity & Inclusion. Mr. Rodriguez is also on the board of Gilead Sciences, Inc. and Denver Metro Chamber of Commerce and Chief Executive Officer & Director at DaVita, Inc. and Senior Vice President for Renal Care Centers Corp. In his past career Mr. Rodriguez was Chairman for DomoBlue SL, Operations Director of CBS Marketing, Inc., President & Chief Executive Officer at DaVita Kidney Care Contracting LLC and Principal at Baxter Healthcare Corp. Mr. Rodriguez received an undergraduate degree from Boston College and an MBA from Harvard Business School.
Harish M. Manwani Harish M. Manwani is Chairman-Executive Board at Indian School of Business and Senior Operating Partner at Blackstone, Inc. and on the board of 6 other companies. In his past career he held the position of Chairman at Alinamin Pharmaceutical Co., Ltd., Chief Operating Officer for Unilever Plc Non-Executive Chairman of Hindustan Unilever Ltd. and President & Chief Executive Officer of Unilever HPC Co. (both are subsidiaries of Unilever Plc) and Member of Economic Development Board of Singapore. He received an undergraduate degree and a graduate degree from the University of Mumbai and a graduate degree from Harvard Business School.